<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>54</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Protective Effect of 25Mg-Porphyrin-Fullerene Nanoparticles on Oxygen-Glucose Deprivation/Reperfusion Injury in PC12 Cells</title>
    <FirstPage>478</FirstPage>
    <LastPage>484</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Peivand</FirstName>
        <LastName>Ghasemzadeh</LastName>
        <affiliation locale="en_US">Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mahdi</FirstName>
        <LastName>Rezayat</LastName>
        <affiliation locale="en_US">Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran. AND School of Advanced Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sharareh</FirstName>
        <LastName>Adeli</LastName>
        <affiliation locale="en_US">Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Rahbar-Roshandel</LastName>
        <affiliation locale="en_US">Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We investigated the effects of 25Mg-Porphyrin-Fullerene nanoparticles, (25MgPMC16) smart ferroporphyrin nanoparticles, on PC12 cells exposed to oxygen-glucose deprivation/reperfusion. In order to explore its effect on cells under oxygen-glucose deprivation conditions, the cultures were pretreated with 25MgPMC16 24 hours prior to oxygen-glucose deprivation/reperfusion. To initiate the oxygen-glucose deprivation/reperfusion, the cell culture medium was replaced with a glucose-free medium and the cells were transferred to a humidified incubation chamber in a mixture of 95% N2 and 5% CO2 at 37&#xB0; C for 30, 60 and 120 min. Cell viability was assessed by MTT assay. Exposure of PC12 cells to 30, 60 and 120 min oxygen-glucose deprivation significantly decreased the cell viability. Pretreatment of the cultures with 25MgPMC16 significantly increased cell viability in a concentration-dependent manner. Pretreatment, the cultures with MK-801 (10 &#xB5;M), a non-competitive NMDA antagonist, has attenuated the cell death after 30 min oxygen-glucose deprivation. We concluded that 25MgPMC16 could protect PC12 cells against oxygen-glucose deprivation/reperfusion-induced cell injury in a concentration-dependent manner. That could be due to the effect of 25MgPMC16 on ATP synthesis and the antioxidant effects of its components.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5880</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5880/4820</pdf_url>
  </Article>
</Articles>
